Length of Life Associated with Pulmonary Venous Obstruction

Sutureless Repair of Extracardiac Univentricular Total Anomalous Pulmonary Venous Connection

Takeaki Harada, Toshihide Nakano, Yuseke Ando, Joji Hashimoto Fukuoka Children’s Hospital.Japan Annals of Thoracic SurgeryAnn Thorac Surg 2023;DOI: 10.1016/j.athoracsur.2023.05.010 AbstractBackground: This study aimed to evaluate the results of sutureless repair of extracardiac total anomalous pulmonary venous connection (TAPVC) with a functional single ventricle at a single institution, including changes in the anastomotic site over time.Methods: The database contained […]

Sutureless Repair of Extracardiac Univentricular Total Anomalous Pulmonary Venous Connection Read More »

Surgical results of total anomalous pulmonary venous connection repair in 256 patients

Takeaki Harada, Toshihide Nakano, Shinichiro Oda, Hideaki Kado Fukuoka Children’s Hospital.Japan Interactive CardioVascular and Thoracic SurgeryInteract Cardiovasc Thorac Surg 2019; 8: 421-426DOI: 10.1093/icvts/ivy267 AbstractObjectives: This study was performed to analyse the surgical results of total anomalous pulmonary venous connection (TAPVC) repair at a single institution and to identify trends and variables associated with mortality and morbidity, particularly

Surgical results of total anomalous pulmonary venous connection repair in 256 patients Read More »

Total anomalous pulmonary venous connection: results of surgical repair of 100 patients at a single institution

Angela M. Kelle, Carl L. Backer, Jeffrey G. Gossett, Sunjay Kaushal, Constantine Mavroudis Northwestern University Feinberg School of Medicine and Children’s Memorial Hospital.United States Journal of Thoracic and Cardiovascular SurgeryJ Thorac Cardiovasc Surg 2010; 139: 1387-1394DOI: 10.1016/j.jtcvs.2010.02.024 AbstractObjective: Surgical repair of total anomalous pulmonary venous connection is associated with significant mortality and morbidity, especially in patients with

Total anomalous pulmonary venous connection: results of surgical repair of 100 patients at a single institution Read More »

Pulmonary vein stenosis and necrotising enterocolitis: is there a possible link with necrotising enterocolitis?

Howard J. Heching, Mariel Turner, Christiana Farkouh-Karoleski, Usha Krishnan Columbia University Medical Center.United States Archives of Diseases in Children Fetal and Neonatal EditionArch Dis Child Fetal Neonatal Ed 2014; 99: F282-F285DOI: 10.1136/archdischild-2013-304740 AbstractObjectives: While acquired pulmonary vein stenosis (PVS) is an often lethal anomaly with poor long-term prognosis and high mortality, little is known about the causes of this

Pulmonary vein stenosis and necrotising enterocolitis: is there a possible link with necrotising enterocolitis? Read More »

Pulmonary Vein Stenosis in Neonates with Severe Bronchopulmonary Dysplasia

Natasha L. Swier, Bernadette Richards, Clifford L. Cua, Susan K. Lynch, Han Yin, Leif D. Nelin, Charles V. Smith, Carl H. Backes Ohio State University Wexner Medical Center and Nationwide Children’s Hospital. University of Washington School of Medicine.United States American Journal of PerinatologyAm J Perinatol 2016; 33: 671-677DOI: 10.1055/s-0035-1571201 AbstractObjectives: Pulmonary vein stenosis (PVS) is a rare, often lethal anomaly associated with poor

Pulmonary Vein Stenosis in Neonates with Severe Bronchopulmonary Dysplasia Read More »

Bilateral disease and early age at presentation are associated with shorter survival in patients with congenital heart disease and intraluminal pulmonary vein stenosis

Sowmya Balasubramanian, Maliha Rehman, Kimberlee Gauvreau, Kathy J. Jenkins Children’s Hospital Boston.United States Congenital Heart DiseaseCongenit Heart Dis 2012; 7: 378-386DOI: 10.1111/j.1747-0803.2012.00647.x AbstractPurpose: Pulmonary vein stenosis (PVS) is a progressive disease that is frequently lethal. We have previously identified neoproliferation of myofibroblasts as the mechanism for progressive intraluminal PVS. PVS occurs in association with other congenital heart

Bilateral disease and early age at presentation are associated with shorter survival in patients with congenital heart disease and intraluminal pulmonary vein stenosis Read More »

A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children

Maliha Rehman, Kathy J. Jenkins, Amy L. Juraszek, Jean A. Connor, Kimberlee Gauvreau, Muhammad Muneeb, Laureen M. Sena, Steven D. Colan, Terry Saia, Mark W. Kieran Children’s Hospital, Boston.United States Congenital Heart DiseaseCongenit Heart Dis 2011; 6: 608-623DOI: 10.1111/j.1747-0803.2011.00574.x AbstractObjective: To determine the safety and efficacy of the chemotherapeutic agents vinblastine and methotrexate in the treatment of

A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children Read More »

Intraluminal Pulmonary Vein Stenosis in Children: A “New” Lesion

Viviane G. Nasr, Ryan Callahan, Zachary Wichner, Kirsten C. Odegard, James A. DiNardo Boston Children’s Hospital.United States Anesthesia and AnalgesiaAnesth Analges 2019; 129: 27-40DOI: 10.1213/ANE.0000000000003924 AbstractPulmonary vein stenosis (PVS) is a rare disorder that leads to progressive narrowing of the extrapulmonary veins. PVS has been reported in both children and adults and in its worse iteration

Intraluminal Pulmonary Vein Stenosis in Children: A “New” Lesion Read More »

Systemic Sirolimus Therapy for Infants and Children With Pulmonary Vein Stenosis

Jay D. Patel, Michael Briones, Mansi Mandhani, Shannon Jones, Divya Suthar, Rosemary Gray, Joelle Pettus, Courtney McCraken, Amanda Thomas, Christopher J. Petit Emory University and Children’s Healthcare of AtlantaUnited States Journal of the American College of CardiologyJ Am Coll Cardiol 2021; 77: 2807-2818DOI: 10.1016/j.jacc.2021.04.013 AbstractBackground: Anatomic interventions for pulmonary vein stenosis (PVS) in infants and children have

Systemic Sirolimus Therapy for Infants and Children With Pulmonary Vein Stenosis Read More »

Multifactorial pulmonary hypertension in infantile scimitar syndrome

Damien Bonnet, Isabelle Szezepanski, Christophe Delacourt, Sophie Malkezadeh-Milani, Maryline Lévy Hôpital Necker-Enfants Malades, AP-HP, Université de ParisFrance Archives of Cardiovascular DiseaseArch Cardiovasc Dis 2022; 115: 142-150DOI: 10.1016/j.acvd.2022.01.004 AbstractBackground: Pulmonary hypertension in infantile scimitar syndrome is highly prevalent at diagnosis, and has a multifactorial origin.Aims: To analyse the constellation of anatomical anomalies and initial physiology, and their contribution

Multifactorial pulmonary hypertension in infantile scimitar syndrome Read More »